Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shock wave or ozone: which works better for stubborn tennis elbow?

NCT ID NCT07427368

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two treatments for people with long-lasting tennis elbow (lateral epicondylitis) that hasn't improved with standard care. Fifty adults will receive either shock wave therapy or an ozone injection once a week for three weeks. Researchers will measure pain, elbow function, grip strength, and tendon changes before treatment, right after, and one month later to see which approach works better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: Male or female patients between 18 and 65 years of age. * Clinical Diagnosis: Patients diagnosed with lateral epicondylitis, defined by pain in the lateral epicondyle region for more than 3 months, increased pain on palpation of the lateral epicondyle, and positive provocation tests (Cozen's, Maudsley's, or Mills' tests). * Symptom Duration: Presence of symptoms for more than 3 months (resistant cases). * Treatment Failure: Lack of response to first-line conservative treatments (e.g., analgesics, exercise, rest, splinting). * Radiographic Confirmation: No other pathology detected on direct radiographs of the elbow. * Injection History: No corticosteroid injection to the affected elbow within the last 6 months. * Consent: Voluntary participation in the study Exclusion Criteria: * Elbow Pathology: Presence of elbow problems other than lateral epicondylitis (e.g., loose bodies, rheumatoid nodules). * Surgical History: History of previous surgery on the affected elbow joint. * Structural Damage: Presence of tendon rupture. * Consent: Unwillingness to continue treatment or participate. * Spinal Pathology: Cervical root pathology (cervical radiculopathy). * Neuropathy: Diagnosed upper extremity entrapment neuropathy. * Neurological Status: Presence of neurological impairment or deficits. * Recent Injections: History of injection therapy to the elbow within the last 6 months. * Recent Therapy: History of physical therapy for the elbow region within the last 6 months. * Pregnancy: Pregnant women. * Hematological: Presence of coagulation or bleeding disorders. * Vascular: Presence of peripheral vasculopathy. * Pain Syndromes: Presence of Complex Regional Pain Syndrome (CRPS). * Oncology: History of malignancy. * Systemic Diseases: Presence of systemic inflammatory or autoimmune disorders (e.g., Rheumatoid Arthritis, SLE). * Trauma: History of direct trauma to the elbow. * Medication: Current use of medications that may affect pain levels or muscle strength (e.g., muscle relaxants, analgesics, gabapentinoids). * Local Infection: Presence of open wounds, infection, or signs of active inflammation in the elbow region. * Cooperation: Difficulty in cooperation or cognitive inability to follow instructions. * Enzyme Deficiency: Congenital Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epicondylitis, lateral are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    RECRUITING

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.